2002
DOI: 10.1001/archotol.128.4.441
|View full text |Cite
|
Sign up to set email alerts
|

Primary Description of a New Entity, Renal Cell–Like Carcinoma of the Nasal Cavity

Abstract: There was no clinical evidence of renal cell carcinoma. The immunohistochemical and ultrastructural findings were inconsistent with the diagnosis of renal cell carcinoma and showed features also inconsistent with the diagnosis of primary salivary clear cell carcinoma. We therefore conclude that this tumor represents a new and distinct entity, notable in its presentation as a "counterfeit renal cell carcinoma."

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
44
1
10

Year Published

2006
2006
2023
2023

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 48 publications
(56 citation statements)
references
References 26 publications
1
44
1
10
Order By: Relevance
“…Both vimentin, which stains the intermediate filaments of tissues of mesenchymal origin, and Pax-8, a marker of mullerian, renal and thyroid tissue, are not expressed in SNRLCA [13]. While the cell of origin of SNRLCA is not established, [7,8,10, 11] DOG-1 and SOX-10 expression confirm the seromucinous phenotype of SNRLCA. Even based on the earlier cases, a seromucinous phenotype was implied given the frequent S100 immunoreactivity, and carbonic anhydrase expression typical of Scheiderian seromucinous glands [10].…”
Section: Discussionmentioning
confidence: 89%
See 4 more Smart Citations
“…Both vimentin, which stains the intermediate filaments of tissues of mesenchymal origin, and Pax-8, a marker of mullerian, renal and thyroid tissue, are not expressed in SNRLCA [13]. While the cell of origin of SNRLCA is not established, [7,8,10, 11] DOG-1 and SOX-10 expression confirm the seromucinous phenotype of SNRLCA. Even based on the earlier cases, a seromucinous phenotype was implied given the frequent S100 immunoreactivity, and carbonic anhydrase expression typical of Scheiderian seromucinous glands [10].…”
Section: Discussionmentioning
confidence: 89%
“…SNRCLA is a relatively new entity that was first described in in 2002 when Zur et al described a patient with a sinonasal clear cell carcinoma resembling renal cell carcinoma in the absence of any underlying primary renal tumor [7]. Since that initial description, additional reports have surfaced and currently there are 13 patients described in the Negative Pax-8 staining (f).…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations